Top Markets
Coin of the day
RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

RP
Clasificación en acciones #38779
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Precio por acción
$0.01100905
Última sincronización: 2025-02-28
Capitalización bursátil
$810.02K
Cambio (1 día)
58.98%
Cambio (1 año)
0.00%
País
CA
Comercio RepliCel Life Sciences Inc. (RP)

Categoría

Número de acciones en circulación de RepliCel Life Sciences Inc. (RP)
Número de acciones en circulación al August 2026: 0
Según los últimos informes financieros y el precio de las acciones de RepliCel Life Sciences Inc., el número actual de acciones en circulación es 0. Al final de August 2026, la empresa tenía 0 acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de RepliCel Life Sciences Inc. (RP) desde 2026 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
Not enough data for the provided dates.
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE